Skip to main content

Animations

MJFF Publications

5941 - 5950 of 6230 Results
Title
Year
  • Year
  • 2017
  • 2021
  • 2016
  • 2018
  • 2022
  • 2020
  • 2011
  • 2024
  • 2018
  • 2019
  • Summary Details
    OPEN
    Title: Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2017.07.007
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.02.006
    Citation Count: 22
  • Summary Details
    OPEN
    Title: The melanoma‐linked “redhead” MC1R influences dopaminergic neuron survival
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.24852
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Inhibition of LRRK2 or Casein Kinase 1 Results in LRRK2 Protein Destabilization
    Journal Name: Molecular Neurobiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s12035-018-1449-2
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00297-9
    Citation Count: 33
  • Summary Details
    OPEN
    Title: CoolMPS: evaluation of antibody labeling based massively parallel non-coding RNA sequencing
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/nar/gkaa1122
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets
    Journal Name: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.bbadis.2011.07.004
    Citation Count: 61
  • Summary Details
    OPEN
    Title: CACHE Challenge #1: Targeting the WDR Domain of LRRK2, A Parkinson’s Disease Associated Protein
    Journal Name: Journal of Chemical Information and Modeling
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jcim.4c01267
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Loss of kallikrein‐related peptidase 7 exacerbates amyloid pathology in Alzheimer's disease model mice
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.201708184
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Heritability and genetic variance of dementia with Lewy bodies
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2019.04.004
    Citation Count: 39
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.